ProShare Advisors
TMDX icon

ProShare Advisors’s Transmedics TMDX Stock Holding History

ProShare Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$537K Sell
5,405
-1,305
-19% -$170K ﹤0.01% 1017
2025
Q4 		$816K Buy
6,710
+287
+4% +$36K ﹤0.01% 891
2025
Q3 		$721K Sell
6,423
-1,178
-15% -$138K ﹤0.01% 927
2025
Q2 		$1.02M Sell
7,601
-309
-4% -$33.9K ﹤0.01% 812
2025
Q1 		$532K Sell
7,910
-2,154
-21% -$148K ﹤0.01% 1059
2024
Q4 		$627K Buy
10,064
+3,870
+62% +$360K ﹤0.01% 1144
2024
Q3 		$972K Buy
6,194
+1,815
+41% +$280K ﹤0.01% 820
2024
Q2 		$660K Sell
4,379
-1,492
-25% -$179K ﹤0.01% 855
2024
Q1 		$434K Buy
5,871
+427
+8% +$35.2K ﹤0.01% 1170
2023
Q4 		$430K Buy
5,444
+1,213
+29% +$73.2K ﹤0.01% 1131
2023
Q3 		$232K Sell
4,231
-18
-0.4% -$1.3K ﹤0.01% 1378
2023
Q2 		$357K Buy
4,249
+658
+18% +$50.4K ﹤0.01% 1160
2023
Q1 		$272K Sell
3,591
-335
-9% -$23.2K ﹤0.01% 1263
2022
Q4 		$242K Buy
+3,926
New +$209K ﹤0.01% 1362
2021
Q3 		– Sell
-6,728
Closed -$223K – 2262
2021
Q2 		$223K Buy
6,728
+9
+0.1% +$249 ﹤0.01% 2087
2021
Q1 		$279K Buy
+6,719
New +$207K ﹤0.01% 1849

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ProShare Advisors's TMDX Position: Q1 2026 in Review

ProShare Advisors reduced its Transmedics (TMDX) stake by 19% in Q1 2026, selling an estimated $170K and leaving 5,405 shares worth $537K. The position accounts for ﹤0.01% of the portfolio, ranked #1017.

ProShare Advisors first reported a position in TMDX in Q1 2021 and has held it in 16 quarters since. The position peaked at $1.02M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • ProShare Advisors held 5,405 shares of Transmedics worth $537K as of Q1 2026.
  • ProShare Advisors sold 1,305 Transmedics shares in Q1 2026, an estimated $170K.
  • Transmedics made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #1017 holding.
  • ProShare Advisors first reported a position in Transmedics in Q1 2021 and has held it in 16 quarters since.
  • ProShare Advisors's Transmedics position peaked at $1.02M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.